US5985A
(en)
|
|
1848-12-26 |
|
Pianoforte-action |
US320A
(en)
|
|
1837-07-31 |
|
John dainty |
US3896111A
(en)
|
1973-02-20 |
1975-07-22 |
Research Corp |
Ansa macrolides
|
US3862925A
(en)
|
1973-07-05 |
1975-01-28 |
American Home Prod |
Preparation of somatotropin release inhibiting factor and intermediates therefor
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
US3842067A
(en)
|
1973-07-27 |
1974-10-15 |
American Home Prod |
Synthesis of(des-asn5)-srif and intermediates
|
JPS5726506B2
(es)
|
1974-03-08 |
1982-06-04 |
|
|
US4105603A
(en)
|
1977-03-28 |
1978-08-08 |
The Salk Institute For Biological Studies |
Peptides which effect release of hormones
|
US4151042A
(en)
|
1977-03-31 |
1979-04-24 |
Takeda Chemical Industries, Ltd. |
Method for producing maytansinol and its derivatives
|
US4137230A
(en)
|
1977-11-14 |
1979-01-30 |
Takeda Chemical Industries, Ltd. |
Method for the production of maytansinoids
|
JPS5562090A
(en)
|
1978-10-27 |
1980-05-10 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4752601A
(en)
|
1983-08-12 |
1988-06-21 |
Immunetech Pharmaceuticals |
Method of blocking immune complex binding to immunoglobulin FC receptors
|
US6054561A
(en)
|
1984-02-08 |
2000-04-25 |
Chiron Corporation |
Antigen-binding sites of antibody molecules specific for cancer antigens
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
US5185432A
(en)
|
1986-02-26 |
1993-02-09 |
Oncogen |
Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US6548640B1
(en)
|
1986-03-27 |
2003-04-15 |
Btg International Limited |
Altered antibodies
|
US5985599A
(en)
|
1986-05-29 |
1999-11-16 |
The Austin Research Institute |
FC receptor for immunoglobulin
|
US4954617A
(en)
|
1986-07-07 |
1990-09-04 |
Trustees Of Dartmouth College |
Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2, Inc., Danville, Calif. |
Geänderte antikörper.
|
US4880078A
(en)
|
1987-06-29 |
1989-11-14 |
Honda Giken Kogyo Kabushiki Kaisha |
Exhaust muffler
|
US5606040A
(en)
|
1987-10-30 |
1997-02-25 |
American Cyanamid Company |
Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
|
US5770701A
(en)
|
1987-10-30 |
1998-06-23 |
American Cyanamid Company |
Process for preparing targeted forms of methyltrithio antitumor agents
|
WO1989007142A1
(en)
|
1988-02-05 |
1989-08-10 |
Morrison Sherie L |
Domain-modified constant region antibodies
|
FR2626882B1
(fr)
|
1988-02-08 |
1991-11-08 |
Ire Celltarg Sa |
Conjugues de derives de vinca comportant une chaine detergente en position c-3
|
US4861579A
(en)
|
1988-03-17 |
1989-08-29 |
American Cyanamid Company |
Suppression of B-lymphocytes in mammals by administration of anti-B-lymphocyte antibodies
|
KR0149012B1
(ko)
|
1988-05-27 |
1998-08-17 |
쇼트보르그 레기날드 데 |
사람 f크롬 수용체 iii
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
US5576184A
(en)
|
1988-09-06 |
1996-11-19 |
Xoma Corporation |
Production of chimeric mouse-human antibodies with specificity to human tumor antigens
|
EP0359096B1
(en)
|
1988-09-15 |
1997-11-05 |
The Trustees Of Columbia University In The City Of New York |
Antibodies having modified carbohydrate content and methods of preparation and use
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
CA2018248A1
(en)
|
1989-06-07 |
1990-12-07 |
Clyde W. Shearman |
Monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use
|
GB8916400D0
(en)
|
1989-07-18 |
1989-09-06 |
Dynal As |
Modified igg3
|
WO1991003493A1
(en)
|
1989-08-29 |
1991-03-21 |
The University Of Southampton |
Bi-or trispecific (fab)3 or (fab)4 conjugates
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
CA2026147C
(en)
|
1989-10-25 |
2006-02-07 |
Ravi J. Chari |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
GB9017024D0
(en)
|
1990-08-03 |
1990-09-19 |
Erba Carlo Spa |
New linker for bioactive agents
|
US5364930A
(en)
|
1990-10-16 |
1994-11-15 |
Northwestern University |
Synthetic C1q peptide fragments
|
GB9105245D0
(en)
|
1991-03-12 |
1991-04-24 |
Lynxvale Ltd |
Binding molecules
|
DE69232706T2
(de)
|
1991-05-01 |
2002-11-28 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine, Rockville |
Verfahren zur behandlung infektiöser respiratorischer erkrankungen
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
GB9112536D0
(en)
|
1991-06-11 |
1991-07-31 |
Celltech Ltd |
Chemical compounds
|
US6800738B1
(en)
|
1991-06-14 |
2004-10-05 |
Genentech, Inc. |
Method for making humanized antibodies
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
US5637481A
(en)
|
1993-02-01 |
1997-06-10 |
Bristol-Myers Squibb Company |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
|
US5223408A
(en)
|
1991-07-11 |
1993-06-29 |
Genentech, Inc. |
Method for making variant secreted proteins with altered properties
|
GB9115364D0
(en)
|
1991-07-16 |
1991-08-28 |
Wellcome Found |
Antibody
|
AU669124B2
(en)
|
1991-09-18 |
1996-05-30 |
Kyowa Hakko Kirin Co., Ltd. |
Process for producing humanized chimera antibody
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
AU2605592A
(en)
|
1991-10-15 |
1993-04-22 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
AU4116793A
(en)
|
1992-04-24 |
1993-11-29 |
Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
GB9225453D0
(en)
|
1992-12-04 |
1993-01-27 |
Medical Res Council |
Binding proteins
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
US6114147A
(en)
|
1993-02-10 |
2000-09-05 |
Unilever Patent Holdings |
Immobilized proteins with specific binding capacities and their use in processes and products
|
US5877396A
(en)
|
1993-04-23 |
1999-03-02 |
Sloan Kettering Institute For Cancer Research |
Mice mutant for functional Fc receptors and method of treating autoimmune diseases
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
US5885573A
(en)
|
1993-06-01 |
1999-03-23 |
Arch Development Corporation |
Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
|
US6180377B1
(en)
|
1993-06-16 |
2001-01-30 |
Celltech Therapeutics Limited |
Humanized antibodies
|
AU691811B2
(en)
|
1993-06-16 |
1998-05-28 |
Celltech Therapeutics Limited |
Antibodies
|
DE69434520T3
(de)
|
1993-07-30 |
2009-10-15 |
Affymax, Inc., Palo Alto |
Biotinylierung von proteinen
|
GB9316989D0
(en)
|
1993-08-16 |
1993-09-29 |
Lynxvale Ltd |
Binding molecules
|
KR960705579A
(ko)
|
1993-11-10 |
1996-11-08 |
에릭에스. 딕커 |
개선된 인터페론 중합체 결합체(Improved interferon polymer conjugates)
|
US5532159A
(en)
|
1994-04-01 |
1996-07-02 |
The Ohio State University |
Monoclonal antibody to canine placental oncofetal protein for detecting cancer
|
US7473423B2
(en)
|
1994-04-29 |
2009-01-06 |
Mayo Foundation For Medical Education And Research |
Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
US6132764A
(en)
|
1994-08-05 |
2000-10-17 |
Targesome, Inc. |
Targeted polymerized liposome diagnostic and treatment agents
|
US5663149A
(en)
|
1994-12-13 |
1997-09-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
US6113898A
(en)
|
1995-06-07 |
2000-09-05 |
Idec Pharmaceuticals Corporation |
Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
US6410690B1
(en)
|
1995-06-07 |
2002-06-25 |
Medarex, Inc. |
Therapeutic compounds comprised of anti-Fc receptor antibodies
|
US5712374A
(en)
|
1995-06-07 |
1998-01-27 |
American Cyanamid Company |
Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
|
US6265150B1
(en)
|
1995-06-07 |
2001-07-24 |
Becton Dickinson & Company |
Phage antibodies
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
US6750334B1
(en)
|
1996-02-02 |
2004-06-15 |
Repligen Corporation |
CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor
|
DK0885002T3
(da)
|
1996-03-04 |
2011-08-22 |
Penn State Res Found |
Materialer og fremgangsmåder til forøgelse af cellulær internalisering
|
DE69731289D1
(de)
|
1996-03-18 |
2004-11-25 |
Univ Texas |
Immunglobulinähnliche domäne mit erhöhten halbwertszeiten
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6300065B1
(en)
|
1996-05-31 |
2001-10-09 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
WO1998005787A1
(en)
|
1996-08-02 |
1998-02-12 |
Bristol-Myers Squibb Company |
A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
|
US6025485A
(en)
|
1997-02-14 |
2000-02-15 |
Arcaris, Inc. |
Methods and compositions for peptide libraries displayed on light-emitting scaffolds
|
US6339069B1
(en)
|
1996-10-15 |
2002-01-15 |
Elan Pharmaceuticalstechnologies, Inc. |
Peptide-lipid conjugates, liposomes and lipsomal drug delivery
|
WO1998023289A1
(en)
|
1996-11-27 |
1998-06-04 |
The General Hospital Corporation |
MODULATION OF IgG BINDING TO FcRn
|
ES2236832T3
(es)
|
1997-01-16 |
2005-07-16 |
Massachusetts Institute Of Technology |
Preparacion de particulas para inhalacion.
|
ATE427966T1
(de)
|
1997-02-11 |
2009-04-15 |
Immunomedics Inc |
Stimulation einer immunantwort durch antikírper, welche mit dem alpha-galaktosylepitop markiert sind
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
US6972323B1
(en)
|
1997-04-01 |
2005-12-06 |
Sankyo Company, Limited |
Anti-Fas antibodies
|
US20030207346A1
(en)
|
1997-05-02 |
2003-11-06 |
William R. Arathoon |
Method for making multispecific antibodies having heteromultimeric and common components
|
DE19721700C1
(de)
|
1997-05-23 |
1998-11-19 |
Deutsches Krebsforsch |
Mutierter OKT3-Antikörper
|
AU4754397A
(en)
|
1997-10-15 |
1999-05-03 |
Medarex, Inc. |
Bispecific molecules directed to tumor associated glycoprotein-72 and fc receptor
|
CA2248971A1
(en)
|
1997-10-31 |
1999-04-30 |
Kyowa Hakko Kogyo Co., Ltd. |
.beta.1, 3-n-acetylglucosaminyltransferase, dna encoding it and its use
|
AU2772199A
(en)
|
1998-02-17 |
1999-08-30 |
Medarex, Inc. |
Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
|
CN1204147C
(zh)
|
1998-02-25 |
2005-06-01 |
利思进药品公司 |
提高以抗体为基础的融合蛋白的循环半衰期的方法
|
PT1490386E
(pt)
|
1998-03-10 |
2008-11-24 |
Genentech Inc |
Novos polipéptidos e ácidos nucleicos que os codificam
|
US6455263B2
(en)
|
1998-03-24 |
2002-09-24 |
Rigel Pharmaceuticals, Inc. |
Small molecule library screening using FACS
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
US6242195B1
(en)
|
1998-04-02 |
2001-06-05 |
Genentech, Inc. |
Methods for determining binding of an analyte to a receptor
|
ES2532910T3
(es)
|
1998-04-02 |
2015-04-01 |
Genentech, Inc. |
Variantes de anticuerpos y fragmentos de los mismos
|
EP0953639A1
(en)
|
1998-04-30 |
1999-11-03 |
Boehringer Ingelheim International GmbH |
FAPalpha-specific antibody with improved producibility
|
DE19819846B4
(de)
|
1998-05-05 |
2016-11-24 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Multivalente Antikörper-Konstrukte
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
EP1089712B1
(en)
|
1998-06-24 |
2003-05-02 |
Advanced Inhalation Research, Inc. |
Large porous particles emitted from an inhaler
|
US6696550B2
(en)
|
1998-07-23 |
2004-02-24 |
Millennium Pharmaceuticals, Inc. |
Humanized anti-CCR2 antibodies and methods of use therefor
|
JP2002522063A
(ja)
|
1998-08-17 |
2002-07-23 |
アブジェニックス インコーポレイテッド |
増加した血清半減期を有する改変された分子の生成
|
GB9818731D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Compounds
|
US7315786B2
(en)
|
1998-10-16 |
2008-01-01 |
Xencor |
Protein design automation for protein libraries
|
WO2000029447A1
(en)
|
1998-11-19 |
2000-05-25 |
Smithkline Beecham Corporation |
Rhamm antagonist antibodies
|
EP1006183A1
(en)
|
1998-12-03 |
2000-06-07 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Recombinant soluble Fc receptors
|
US7183387B1
(en)
|
1999-01-15 |
2007-02-27 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
BR0008758A
(pt)
|
1999-01-15 |
2001-12-04 |
Genentech Inc |
Variantes de polipeptìdeos parentais com funçãoefetora alterada, polipeptìdeos, composição ácidonucleico isolado, vetor, célula hospedeira,método para produzir uma variante depolipeptìdeo, método para o tratamento de umadesordem em mamìferos e método para produziruma região fc variante
|
CN1360596A
(zh)
|
1999-02-12 |
2002-07-24 |
遗传研究所有限公司 |
与b7分子发生反应的人源化免疫球蛋白及应用该免疫球蛋白的治疗方法
|
US7109292B2
(en)
|
1999-03-08 |
2006-09-19 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7527787B2
(en)
|
2005-10-19 |
2009-05-05 |
Ibc Pharmaceuticals, Inc. |
Multivalent immunoglobulin-based bioactive assemblies
|
WO2000068266A1
(en)
|
1999-05-11 |
2000-11-16 |
Eli Lilly And Company |
Amyloid precursor protein protease and related nucleic acid compounds
|
EP1514933A1
(en)
|
1999-07-08 |
2005-03-16 |
Research Association for Biotechnology |
Secretory protein or membrane protein
|
AU7337400A
(en)
|
1999-09-03 |
2001-04-10 |
Human Genome Sciences, Inc. |
B7-like polynucleotides, polypeptides, and antibodies
|
US6429303B1
(en)
|
1999-09-03 |
2002-08-06 |
Curagen Corporation |
Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
|
US6406840B1
(en)
|
1999-12-17 |
2002-06-18 |
Biomosaic Systems, Inc. |
Cell arrays and the uses thereof
|
US6541225B1
(en)
|
2000-01-26 |
2003-04-01 |
Raven Biotechnologies, Inc. |
Methods and compositions for generating human monoclonal antibodies
|
DE60122286T2
(de)
|
2000-02-11 |
2007-08-02 |
Merck Patent Gmbh |
Steigerung der zirkulierenden halbwertzeit von auf antikörpern basierenden fusionsproteinen
|
HUP0300919A2
(hu)
|
2000-03-24 |
2003-07-28 |
Micromet Ag |
Többfunkciós polipeptidek NKG2D receptor komplex epitóp kötőhellyel
|
CA2399940A1
(en)
|
2000-04-13 |
2001-10-25 |
The Rockefeller University |
Enhancement of antibody-mediated immune responses
|
US20060154313A1
(en)
|
2000-04-13 |
2006-07-13 |
Immunex Corporation |
Human B7 polypeptide B7-H3A
|
WO2001094413A2
(en)
|
2000-06-06 |
2001-12-13 |
Bristol-Myers Squibb Company |
B7-related nucleic acids and polypeptides and their uses for immunomodulation
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
EP1892251A3
(en)
|
2000-06-06 |
2008-12-31 |
Brystol-Myers Squibb Company |
B7-related nucleic acids and polypeptides and their uses for immunomodulation
|
CA2410551A1
(en)
|
2000-06-30 |
2002-01-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw (Vib) |
Heterodimeric fusion proteins
|
WO2002010187A1
(en)
|
2000-07-27 |
2002-02-07 |
Mayo Foundation For Medical Education And Research |
B7-h3 and b7-h4, novel immunoregulatory molecules
|
EP1327638A4
(en)
|
2000-09-12 |
2004-09-29 |
Kirin Brewery |
NEW WALL MEMBRANE OF DENDRITIC CELLS AND THEIR USE
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
US7737258B2
(en)
|
2000-10-18 |
2010-06-15 |
Sloan-Kettering Institute For Cancer Research |
Uses of monoclonal antibody 8H9
|
CA2423843A1
(en)
|
2000-10-18 |
2002-04-25 |
Sloan-Kettering Institute For Cancer Research |
Uses of monoclonal antibody 8h9
|
JP4336498B2
(ja)
|
2000-12-12 |
2009-09-30 |
メディミューン,エルエルシー |
延長した半減期を有する分子ならびにその組成物および用途
|
EP1243276A1
(en)
*
|
2001-03-23 |
2002-09-25 |
Franciscus Marinus Hendrikus De Groot |
Elongated and multiple spacers containing activatible prodrugs
|
CA2444680A1
(en)
|
2001-04-18 |
2002-10-31 |
Dyax Corp. |
Binding molecules for fc-region polypeptides
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
US7318923B2
(en)
|
2001-04-30 |
2008-01-15 |
Eli Lilly And Company |
Humanized anti-βantibodies
|
US6972324B2
(en)
|
2001-05-18 |
2005-12-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Antibodies specific for CD44v6
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
DE60124912T2
(de)
|
2001-09-14 |
2007-06-14 |
Affimed Therapeutics Ag |
Multimerische, einzelkettige, Tandem-Fv-Antikörper
|
EP1439857B1
(en)
|
2001-10-12 |
2009-02-25 |
Schering Corporation |
USE OF BISPECIFIC ANTIBODIES BINDING TO THE ACTIVATING RECEPTOR FcEpsilonRI AND TO THE INHIBITING RECEPTOR OX2Ra (CD200Ra) TO REGULATE IMMUNE RESPONSES
|
US20030157108A1
(en)
|
2001-10-25 |
2003-08-21 |
Genentech, Inc. |
Glycoprotein compositions
|
AU2002359851A1
(en)
|
2001-12-21 |
2003-07-30 |
Idexx Laboratories, Inc. |
Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
|
AU2003206264A1
(en)
|
2002-02-07 |
2003-09-02 |
Vereniging Voor Christelijk Wetenschappelijk Onderwijs |
MODULATING TOLERANCE BY MODULATING FcGammaRIIB RECEPTOR SIGNALLING
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
US7585491B2
(en)
|
2002-12-13 |
2009-09-08 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
US8188231B2
(en)
|
2002-09-27 |
2012-05-29 |
Xencor, Inc. |
Optimized FC variants
|
US20040110226A1
(en)
|
2002-03-01 |
2004-06-10 |
Xencor |
Antibody optimization
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
EP1354600A1
(en)
|
2002-04-19 |
2003-10-22 |
Affimed Therapeutics AG |
Antibody combination useful for tumor therapy
|
WO2003094859A2
(en)
|
2002-05-10 |
2003-11-20 |
Medimmune, Inc. |
Epha2 monoclonal antibodies and methods of use thereof
|
US7351803B2
(en)
|
2002-05-30 |
2008-04-01 |
Macrogenics, Inc. |
CD16A binding proteins and use for the treatment of immune disorders
|
AU2003243749B2
(en)
|
2002-06-19 |
2010-03-11 |
Macrogenics West, Inc. |
Novel RAAG10 cell surface target and a family of antibodies recognizing that target
|
US7776814B2
(en)
|
2002-07-09 |
2010-08-17 |
R&D-Biopharmaceuticals Gmbh |
Tubulysin conjugates
|
CA2494310A1
(en)
|
2002-08-01 |
2004-02-12 |
Immunomedics, Inc. |
Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
|
US8946387B2
(en)
|
2002-08-14 |
2015-02-03 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8044180B2
(en)
|
2002-08-14 |
2011-10-25 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8193318B2
(en)
|
2002-08-14 |
2012-06-05 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8968730B2
(en)
|
2002-08-14 |
2015-03-03 |
Macrogenics Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8530627B2
(en)
|
2002-08-14 |
2013-09-10 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US20090017023A1
(en)
|
2002-08-14 |
2009-01-15 |
Macrogenics, Inc. |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
|
US8187593B2
(en)
|
2002-08-14 |
2012-05-29 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
EP1534335B9
(en)
|
2002-08-14 |
2016-01-13 |
Macrogenics, Inc. |
Fcgammariib-specific antibodies and methods of use thereof
|
EP3150630A1
(en)
|
2002-09-27 |
2017-04-05 |
Xencor Inc. |
Optimized fc variants and methods for their generation
|
US7217797B2
(en)
|
2002-10-15 |
2007-05-15 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
US7960512B2
(en)
|
2003-01-09 |
2011-06-14 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
CA2512729C
(en)
|
2003-01-09 |
2014-09-16 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
EP1596804A4
(en)
|
2003-01-13 |
2008-02-06 |
Macrogenics Inc |
SOLUBLE FCyR FUSION PROTEINS AND METHODS OF USE
|
DE10303664A1
(de)
|
2003-01-23 |
2004-08-12 |
Nemod Immuntherapie Ag |
Erkennungsmoleküle zur Behandlung und Detektion von Tumoren
|
US20090010920A1
(en)
|
2003-03-03 |
2009-01-08 |
Xencor, Inc. |
Fc Variants Having Decreased Affinity for FcyRIIb
|
WO2004080979A1
(en)
|
2003-03-14 |
2004-09-23 |
Lg Life Sciences Ltd. |
Novel 3-(2-amino-4-pyrimidinyl)-4-hydroxyphenyl ketone derivatives
|
US20050002935A1
(en)
|
2003-04-17 |
2005-01-06 |
Vincent Ling |
Use of B7-H3 as an immunoregulatory agent
|
AR044388A1
(es)
|
2003-05-20 |
2005-09-07 |
Applied Molecular Evolution |
Moleculas de union a cd20
|
AU2003265522A1
(en)
|
2003-08-18 |
2005-03-10 |
Macrogenics, Inc. |
FCGammaRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
|
BRPI0414513A
(pt)
|
2003-09-18 |
2007-01-02 |
Raven Biotechnologies Inc |
kid3 e anticorpos de kid3 que se ligam a ele
|
AU2004284075A1
(en)
|
2003-10-22 |
2005-05-06 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
|
CA2841741C
(en)
|
2003-11-06 |
2020-01-07 |
Seattle Genetics, Inc. |
Monomethylvaline compounds capable of conjugation to ligands
|
EP1697415A1
(en)
|
2003-11-12 |
2006-09-06 |
Biogen Idec MA Inc. |
NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
EP2154157A3
(en)
|
2004-01-12 |
2010-04-28 |
Applied Molecular Evolution Inc. |
FC region variants
|
WO2005070966A2
(en)
|
2004-01-16 |
2005-08-04 |
Regeneron Pharmaceuticals, Inc. |
Fusion polypeptides capable of activating receptors
|
WO2007046893A2
(en)
|
2005-10-19 |
2007-04-26 |
Ibc Pharmaceuticals, Inc. |
Methods for generating bioactive assemblies and uses thereof
|
CA2556752C
(en)
|
2004-02-23 |
2016-02-02 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
SI1720881T1
(sl)
|
2004-03-01 |
2013-04-30 |
Spirogen Sarl |
11-hidroksi-5H-pirolo(2,1-c)(1,4)benzodiazepin-5onski derivati kot ključni intermediati za pipravo C2 substituiranih pirolobenzodiazepinov
|
US20070135338A1
(en)
|
2004-03-31 |
2007-06-14 |
Karyn O'neil |
Human GLP-1 mimetibodies, compositions, methods and uses
|
KR20070038453A
(ko)
|
2004-04-16 |
2007-04-10 |
마크로제닉스, 인크. |
FcγRIIB-특이적 항체 및 그의 사용 방법
|
KR101297146B1
(ko)
|
2004-05-10 |
2013-08-21 |
마크로제닉스, 인크. |
인간화 FcγRIIB 특이적 항체 및 그의 사용 방법
|
GB0410725D0
(en)
|
2004-05-13 |
2004-06-16 |
Spirogen Ltd |
Pyrrolobenzodiazepine therapeutic agents
|
BRPI0511782B8
(pt)
|
2004-06-03 |
2021-05-25 |
Novimmune Sa |
anticorpos anti-cd3, uso e método de produção dos mesmos, composição farmacêutica, molécula de ácido nucleico isolada e vetor
|
WO2005121179A2
(en)
|
2004-06-07 |
2005-12-22 |
Raven Biotechnologies, Inc. |
Transferrin receptor antibodies
|
AU2005265163B2
(en)
|
2004-06-18 |
2009-10-01 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
KR20110050567A
(ko)
|
2004-07-22 |
2011-05-13 |
제넨테크, 인크. |
Her2 항체 조성물
|
EP2412728B1
(en)
|
2004-08-03 |
2015-01-07 |
Innate Pharma |
Therapeutic compositions against cancer targeting 4IG-B7-H3
|
PL2213683T3
(pl)
|
2004-08-04 |
2013-10-31 |
Mentrik Biotech Llc |
WARIANTY REGIONÓW Fc
|
US7662926B2
(en)
|
2004-09-02 |
2010-02-16 |
Genentech, Inc. |
Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
|
AU2005282720B2
(en)
|
2004-09-02 |
2011-08-04 |
Genentech, Inc. |
Anti-FC-gamma RIIB receptor antibody and uses therefor
|
US7655229B2
(en)
|
2004-09-02 |
2010-02-02 |
Chan Andrew C |
Anti-FC-gamma RIIB receptor antibody and uses therefor
|
AU2005335714B2
(en)
|
2004-11-10 |
2012-07-26 |
Macrogenics, Inc. |
Engineering Fc antibody regions to confer effector function
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
BRPI0517837A
(pt)
|
2004-11-12 |
2008-10-21 |
Xencor Inc |
variantes fc com ligação alterada a fcrn
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
WO2006066078A2
(en)
|
2004-12-15 |
2006-06-22 |
Magrogenics, Inc. |
Fcϝriib-specific antibodies and methods of use thereof
|
WO2006076584A2
(en)
|
2005-01-12 |
2006-07-20 |
Raven Biotechnologies, Inc. |
Kid31 and antibodies that bind thereto
|
EP1846032A4
(en)
|
2005-01-31 |
2009-01-28 |
Raven Biotechnologies Inc |
LUCA2 AND ANTIBODY BINDING
|
EP1841794B1
(en)
|
2005-02-02 |
2013-11-20 |
MacroGenics West, Inc. |
Adam-9 modulators
|
AU2006210606B2
(en)
|
2005-02-03 |
2012-03-22 |
Macrogenics West, Inc. |
Antibodies to Oncostatin M receptor
|
BRPI0607450A2
(pt)
|
2005-02-04 |
2009-09-01 |
Raven Biotechnologies Inc |
anticorpos que se ligam a epha2 e métodos para sua utilização
|
US20060193849A1
(en)
|
2005-02-25 |
2006-08-31 |
Antisoma Plc |
Biological materials and uses thereof
|
CN101484182B
(zh)
|
2005-04-06 |
2014-06-11 |
Ibc药品公司 |
由同二聚体、同四聚体或二聚体的二聚体组成的稳定连接复合体的生产方法及用途
|
AU2006232310B9
(en)
|
2005-04-06 |
2011-07-21 |
Ibc Pharmaceuticals, Inc. |
Improved stably tethered structures of defined compositions with multiple functions or binding specificities
|
WO2006110593A2
(en)
|
2005-04-07 |
2006-10-19 |
Macrogenics, Inc. |
Biological targets for the diagnosis, treatment and prevention of cancer
|
US9284375B2
(en)
|
2005-04-15 |
2016-03-15 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
US9963510B2
(en)
|
2005-04-15 |
2018-05-08 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
ES2707152T3
(es)
|
2005-04-15 |
2019-04-02 |
Macrogenics Inc |
Diacuerpos covalentes y usos de los mismos
|
US8101183B2
(en)
|
2005-05-06 |
2012-01-24 |
Zymogentics, Inc. |
Variable region sequences of IL-31 monoclonal antibodies
|
GB0510790D0
(en)
|
2005-05-26 |
2005-06-29 |
Syngenta Crop Protection Ag |
Anti-CD16 binding molecules
|
JP2009500457A
(ja)
|
2005-07-11 |
2009-01-08 |
マクロジェニクス,インコーポレーテッド |
毒性の低下した免疫抑制モノクローナル抗体を使用する自己免疫疾患の治療法
|
CA2614766A1
(en)
|
2005-07-11 |
2007-01-18 |
Macrogenics, Inc. |
Methods of treating autoimmune disease using humanized anti-cd16a antibodies
|
CA2618681C
(en)
|
2005-08-10 |
2015-10-27 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
EP2520588A1
(en)
|
2005-08-19 |
2012-11-07 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
DE602006006199D1
(de)
|
2005-10-05 |
2009-05-20 |
Spirogen Ltd |
4-ä4-(5-oxo-2,3,5,11a-tetrahydro-5h-pyrrolo ä2, 1-cüä1,4übenzodiazepin-8-yloxy)-butyrylaminoü-1h-pyrrol-2-carbonsäurealkylesterderivate und verwandte verbindung zur behandlung einer proliferativen erkrankung
|
WO2007055916A2
(en)
|
2005-11-07 |
2007-05-18 |
The Rockefeller University |
Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
|
FR2894982A1
(fr)
|
2005-12-16 |
2007-06-22 |
Lab Francais Du Fractionnement |
Procede de preparation d'anticorps selectifs des recepteurs fc activateurs
|
EP1959993B1
(en)
|
2005-12-16 |
2014-11-19 |
IBC Pharmaceuticals, Inc. |
Multivalent immunoglobulin-based bioactive assemblies
|
AU2007226752A1
(en)
|
2006-03-10 |
2007-09-20 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant heavy chains and methods of using same
|
EP1999154B1
(en)
|
2006-03-24 |
2012-10-24 |
Merck Patent GmbH |
Engineered heterodimeric protein domains
|
WO2007117600A2
(en)
|
2006-04-07 |
2007-10-18 |
Macrogenics, Inc. |
Combination therapy for treating autoimmune diseases
|
ES2489646T3
(es)
|
2006-05-26 |
2014-09-02 |
Macrogenics, Inc. |
Anticuerpos humanizados específicos a Fc gamma RIIB y sus métodos de uso
|
US8409577B2
(en)
|
2006-06-12 |
2013-04-02 |
Emergent Product Development Seattle, Llc |
Single chain multivalent binding proteins with effector function
|
EP2037961B1
(en)
|
2006-06-14 |
2015-11-11 |
MacroGenics, Inc. |
Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity
|
LT2029173T
(lt)
|
2006-06-26 |
2016-11-10 |
Macrogenics, Inc. |
Fc riib specifiniai antikūnai ir jų panaudojimo būdai
|
WO2008002933A2
(en)
|
2006-06-26 |
2008-01-03 |
Macrogenics, Inc. |
Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof
|
US8206709B2
(en)
|
2006-06-30 |
2012-06-26 |
Novo Nordisk A/S |
Anti-NKG2A antibodies and uses thereof
|
AT503889B1
(de)
|
2006-07-05 |
2011-12-15 |
Star Biotechnologische Forschungs Und Entwicklungsges M B H F |
Multivalente immunglobuline
|
AT503902B1
(de)
|
2006-07-05 |
2008-06-15 |
F Star Biotech Forsch & Entw |
Verfahren zur manipulation von immunglobulinen
|
US10118970B2
(en)
|
2006-08-30 |
2018-11-06 |
Genentech, Inc. |
Multispecific antibodies
|
US20080112961A1
(en)
|
2006-10-09 |
2008-05-15 |
Macrogenics, Inc. |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
|
US7718774B2
(en)
|
2006-11-08 |
2010-05-18 |
Macrogenics, Inc. |
TES7 and antibodies that bind thereto
|
US7992748B2
(en)
|
2006-11-17 |
2011-08-09 |
North Safety Products, Inc. |
Earplug dispenser
|
PT2099823E
(pt)
|
2006-12-01 |
2014-12-22 |
Seattle Genetics Inc |
Agentes de ligação ao alvo variantes e suas utilizações
|
EA019661B1
(ru)
|
2006-12-08 |
2014-05-30 |
Лексикон Фармасьютикалз, Инк. |
Моноклональные антитела против angptl3
|
WO2008140603A2
(en)
|
2006-12-08 |
2008-11-20 |
Macrogenics, Inc. |
METHODS FOR THE TREATMENT OF DISEASE USING IMMUNOGLOBULINS HAVING FC REGIONS WITH ALTERED AFFINITIES FOR FCγR ACTIVATING AND FCγR INHIBITING
|
WO2008079713A2
(en)
|
2006-12-21 |
2008-07-03 |
Macrogenics Inc. |
Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity
|
TWI412367B
(zh)
|
2006-12-28 |
2013-10-21 |
Medarex Llc |
化學鏈接劑與可裂解基質以及其之綴合物
|
WO2008091908A2
(en)
|
2007-01-22 |
2008-07-31 |
Raven Biotechnologies |
Human cancer stem cells
|
WO2008116219A2
(en)
|
2007-03-22 |
2008-09-25 |
Sloan-Kettering Institute For Cancer Research |
Uses of monoclonal antibody 8h9
|
AU2008234019B2
(en)
|
2007-04-03 |
2014-05-29 |
Amgen Research (Munich) Gmbh |
Cross-species-specific bispecific binders
|
FR2916763B1
(fr)
|
2007-05-31 |
2013-11-15 |
Biomerieux Sa |
Nouveaux substrats de peptidase
|
CN101821288A
(zh)
|
2007-06-21 |
2010-09-01 |
宏观基因有限公司 |
共价双抗体及其用途
|
AU2008282218A1
(en)
|
2007-07-31 |
2009-02-05 |
Medimmune, Llc |
Multispecific epitope binding proteins and uses thereof
|
EP2532676B1
(en)
|
2007-08-15 |
2017-03-22 |
Bayer Pharma Aktiengesellschaft |
Protease-regulated antibody
|
BRPI0818963A2
(pt)
|
2007-11-30 |
2015-05-05 |
Bristol Myers Squibb Co |
Conjugado anticorpo-molécula parceira e método para tratar câncer em um indivíduo
|
US8802089B2
(en)
|
2008-01-03 |
2014-08-12 |
Genmab A/S |
Monoclonal antibodies against CD32B
|
LT2247304T
(lt)
|
2008-04-02 |
2016-10-25 |
Macrogenics, Inc. |
Her2/neu atžvilgiu specifiniai antikūna ir jų panaudojimo būdai
|
KR101614494B1
(ko)
|
2008-04-02 |
2016-04-22 |
마크로제닉스, 인크. |
Bcr-복합체-특이적 항체 및 그것의 사용 방법
|
US20090262732A1
(en)
|
2008-04-16 |
2009-10-22 |
Barry Wood |
Data Communications Network
|
EP2113255A1
(en)
|
2008-05-02 |
2009-11-04 |
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. |
Cytotoxic immunoglobulin
|
WO2010033279A2
(en)
|
2008-06-04 |
2010-03-25 |
Macrogenics, Inc. |
Antibodies with altered binding to fcrn and methods of using same
|
WO2010027797A1
(en)
|
2008-08-26 |
2010-03-11 |
Macrogenics Inc. |
T-cell receptor antibodies and methods of use thereof
|
WO2010028797A1
(en)
|
2008-09-10 |
2010-03-18 |
F. Hoffmann-La Roche Ag |
Multivalent antibodies
|
WO2010028796A1
(en)
|
2008-09-10 |
2010-03-18 |
F. Hoffmann-La Roche Ag |
Trispecific hexavalent antibodies
|
WO2010028795A1
(en)
|
2008-09-10 |
2010-03-18 |
F. Hoffmann-La Roche Ag |
Multivalent antibodies
|
AU2009320481C1
(en)
|
2008-11-03 |
2016-12-08 |
Syntarga B.V. |
Novel CC-1065 analogs and their conjugates
|
RU2593720C2
(ru)
|
2008-12-19 |
2016-08-10 |
Макродженикс, Инк. |
Ковалентные диантитела и их применение
|
WO2010093395A1
(en)
|
2009-02-13 |
2010-08-19 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
PE20120539A1
(es)
|
2009-03-20 |
2012-05-12 |
Genentech Inc |
Anticuerpos anti-her biespecifico
|
AU2010252284A1
(en)
|
2009-05-27 |
2011-11-17 |
F. Hoffmann-La Roche Ag |
Tri- or tetraspecific antibodies
|
US8277919B2
(en)
|
2009-07-23 |
2012-10-02 |
VMO Systems, Inc. |
Reflective coating for an optical disc
|
CA2776385C
(en)
|
2009-10-07 |
2019-04-09 |
Macrogenics, Inc. |
Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
|
GB201000467D0
(en)
|
2010-01-12 |
2010-02-24 |
Ucb Pharma Sa |
Antibodies
|
US20110206672A1
(en)
|
2010-02-25 |
2011-08-25 |
Melvyn Little |
Antigen-Binding Molecule And Uses Thereof
|
PL2361936T3
(pl)
|
2010-02-25 |
2016-10-31 |
|
Cząsteczka wiążąca antygen i jej zastosowania
|
US8802091B2
(en)
*
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
EP2542256B1
(en)
|
2010-03-04 |
2019-05-22 |
MacroGenics, Inc. |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
RU2578719C9
(ru)
|
2010-04-21 |
2016-10-10 |
Синтарга Б.В. |
Новые конъюгаты аналогов сс-1065 и бифункциональные линкеры
|
KR101860963B1
(ko)
|
2010-04-23 |
2018-05-24 |
제넨테크, 인크. |
이종다량체 단백질의 생산
|
JP6022444B2
(ja)
|
2010-05-14 |
2016-11-09 |
ライナット ニューロサイエンス コーポレイション |
ヘテロ二量体タンパク質ならびにそれを生産および精製するための方法
|
US20130115215A1
(en)
|
2010-07-14 |
2013-05-09 |
Hongxing Zhou |
Domain insertion immunoglobulin
|
CN103154025B
(zh)
|
2010-08-02 |
2015-07-01 |
宏观基因有限公司 |
共价双抗体及其用途
|
EA025471B1
(ru)
|
2010-08-06 |
2016-12-30 |
Эндосайт, Инк. |
Способы получения тубулизинов
|
DK2635607T3
(da)
|
2010-11-05 |
2019-11-18 |
Zymeworks Inc |
Stabilt heterodimert antistofdesign med mutationer i fc-domænet
|
EP2670440B1
(en)
*
|
2011-02-01 |
2018-09-05 |
Genmab A/S |
Human antibodies and antibody-drug conjugates against cd74
|
WO2013119903A1
(en)
|
2012-02-10 |
2013-08-15 |
Research Corporation Technologies, Inc. |
Fusion proteins comprising immunoglobulin constant domain-derived scaffolds
|
PL2703486T3
(pl)
|
2011-04-25 |
2018-07-31 |
Daiichi Sankyo Company, Limited |
Przeciwciało anty-b7-h3
|
WO2012156430A1
(en)
|
2011-05-17 |
2012-11-22 |
Trion Research Gmbh |
Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties
|
UA115402C2
(uk)
|
2011-05-21 |
2017-10-25 |
Макродженікс, Інк. |
Cd3-зв'язувальна молекула, здатна до зв'язування з cd3 людини і cd3, що не є людським
|
SG195073A1
(en)
|
2011-05-21 |
2013-12-30 |
Macrogenics Inc |
Deimmunized serum-binding domains and their use for extending serum half-life
|
WO2012162583A1
(en)
|
2011-05-26 |
2012-11-29 |
Ibc Pharmaceuticals, Inc. |
Design and construction of novel multivalent antibodies
|
WO2013003647A2
(en)
|
2011-06-28 |
2013-01-03 |
Sea Lane Biotechnologies, Llc |
Multispecific stacked variable domain binding proteins
|
EP2729488A4
(en)
|
2011-07-06 |
2015-01-14 |
Medimmune Llc |
PROCESS FOR PREPARING MULTIMANT POLYPEPTIDES
|
US9920438B2
(en)
|
2011-07-07 |
2018-03-20 |
Massachusetts Institute Of Technology |
Methods and apparatus for ultrathin catalyst layer for photoelectrode
|
AU2011373925B2
(en)
|
2011-07-22 |
2016-04-28 |
Affimed Therapeutics Ag |
Multivalent antigen-binding Fv molecule
|
AU2012336069A1
(en)
|
2011-11-07 |
2014-05-22 |
Medimmune, Llc |
Multispecific and multivalent binding proteins and uses thereof
|
WO2013163427A1
(en)
|
2012-04-25 |
2013-10-31 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Antibodies to treat hiv-1 infection
|
CN104379604A
(zh)
|
2012-05-24 |
2015-02-25 |
弗·哈夫曼-拉罗切有限公司 |
多特异性抗体
|
SG11201408646VA
(en)
|
2012-07-06 |
2015-01-29 |
Genmab Bv |
Dimeric protein with triple mutations
|
US20150203591A1
(en)
|
2012-08-02 |
2015-07-23 |
Regeneron Pharmaceuticals, Inc. |
Mutivalent antigen-binding proteins
|
KR102540419B1
(ko)
*
|
2012-10-11 |
2023-06-05 |
다이이찌 산쿄 가부시키가이샤 |
글리신아미드 화합물의 제조 방법
|
CN105102068B
(zh)
|
2012-10-12 |
2018-06-01 |
Adc疗法责任有限公司 |
吡咯并苯并二氮杂卓-抗体结合物
|
US9872924B2
(en)
|
2012-10-19 |
2018-01-23 |
Daiichi Sankyo Company, Limited |
Antibody-drug conjugate produced by binding through linker having hydrophilic structure
|
US9487587B2
(en)
|
2013-03-05 |
2016-11-08 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
|
US9562099B2
(en)
|
2013-03-14 |
2017-02-07 |
Genentech, Inc. |
Anti-B7-H4 antibodies and immunoconjugates
|
EP2840091A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific diabodies that are capable of binding gpA33 and CD3 and uses thereof
|
AU2014312215B2
(en)
|
2013-08-28 |
2020-02-27 |
Abbvie Stemcentrx Llc |
Site-specific antibody conjugation methods and compositions
|
PL3069735T3
(pl)
*
|
2014-01-10 |
2018-08-31 |
Synthon Biopharmaceuticals B.V. |
ADC duokarmycyny do zastosowania w leczeniu raka pęcherza
|
PL3092010T3
(pl)
|
2014-01-10 |
2019-01-31 |
Synthon Biopharmaceuticals B.V. |
Sposób oczyszczania połączonych cysteiną koniugatów przeciwciało-lek
|
JP6533534B2
(ja)
|
2014-02-14 |
2019-06-19 |
マクロジェニクス,インコーポレーテッド |
膠芽腫の治療に使用するための組成物及びその使用
|
US9427479B2
(en)
|
2014-04-11 |
2016-08-30 |
Medimmune Llc |
Tubulysin derivatives
|
TWI747041B
(zh)
|
2014-05-29 |
2021-11-21 |
美商宏觀基因股份有限公司 |
三特異性結合分子及其使用方法
|
PL3152191T3
(pl)
|
2014-06-05 |
2019-10-31 |
Synthon Biopharmaceuticals Bv |
Ulepszony sposób wytwarzania proleków duokarmycyny
|
TW201617368A
(zh)
*
|
2014-09-05 |
2016-05-16 |
史坦森特瑞斯公司 |
新穎抗mfi2抗體及使用方法
|
WO2016044383A1
(en)
*
|
2014-09-17 |
2016-03-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-cd276 antibodies (b7h3)
|
CN112125929A
(zh)
|
2015-06-15 |
2020-12-25 |
杭州多禧生物科技有限公司 |
用于偶联的亲水链接体
|
CN113350518A
(zh)
|
2015-07-12 |
2021-09-07 |
杭州多禧生物科技有限公司 |
与细胞结合分子的共轭偶联的桥连接体
|
US10292961B2
(en)
|
2015-07-15 |
2019-05-21 |
Hangzhou Dac Biotech Co., Ltd. |
Disulfur bridge linkers for conjugation of a cell-binding molecule
|
US11174315B2
(en)
|
2015-10-08 |
2021-11-16 |
Macrogenics, Inc. |
Combination therapy for the treatment of cancer
|
WO2017062615A2
(en)
|
2015-10-08 |
2017-04-13 |
Macrogenics, Inc. |
Combination therapy for the treatment of cancer
|
WO2017114550A1
(en)
|
2015-12-28 |
2017-07-06 |
Telecom Italia S.P.A. |
Method for managing the reputation of members of an online community
|
JP7002467B2
(ja)
|
2016-04-15 |
2022-01-20 |
マクロジェニクス,インコーポレーテッド |
新規のb7‐h3結合分子、その抗体薬物コンジュゲート、及びその使用方法
|
SG11201907753TA
(en)
|
2017-02-24 |
2019-09-27 |
Macrogenics Inc |
Bispecific binding molecules that are capable of binding cd137 and tumor antigens, and uses thereof
|